roseomonas
Botanicalexperimental
Roseomonas is a genus of Gram negative bacteria. The cells are coccoid rods when viewed microscopically. Certain species are known to be opportunistic infections for humans. — Wikipedia
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Jan 3, 2017 (NCT03018275)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRoseomonas ↗
Also known as
- roseomonas
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06096857 | Phase 3 | Jan 3, 2024 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT04936113 | Phase 2 | Jun 2, 2021 | Forte Biosciences, Inc. |
| NCT04504279 | Phase 2 | Oct 13, 2020 | Forte Biosciences, Inc. |
| NCT03018275 | Phase 1/Phase 2 (Phase 2) | Jan 3, 2017 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Forte Biosciences, Inc. | For profit | 2 | 2 | 1 | 2020 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2017 |
2 organizations
Page 1 / 1